Credit Suisse Ag Lexicon Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.06 - $2.33 $6,035 - $13,267	-5,694 Reduced 3.76%	145,746 $158,000
Q2 2023 Aug 11, 2023	BUY	$2.15 - $3.49 $189,318 - $307,311	88,055 Added 138.92%	151,440 $346,000
Q1 2023 May 10, 2023	BUY	$1.99 - $2.68 $39 - $53	20 Added 0.03%	63,385 $154,000
Q4 2022 Feb 13, 2023	BUY	$1.8 - $2.56 $42,987 - $61,137	23,882 Added 60.49%	63,365 $121,000
Q3 2022 Nov 10, 2022	BUY	$1.94 - $3.43 $985 - $1,742	508 Added 1.3%	39,483 $95,000

Q2 2022 Aug 12, 2022	SELL	$1.31 - $2.69 $5,469 - $11,230	-4,175 Reduced 9.68%	38,975 $72,000
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $791 - $1,579	406 Added 0.95%	43,150 $90,000
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $8,625 - $13,946	-2,264 Reduced 5.03%	42,744 $168,000
Q3 2021 Nov 12, 2021	BUY	$3.38 - $5.35 $45,447 - $71,936	13,446 Added 42.6%	45,008 $216,000
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $84,567 - $120,487	20,526 Added 185.99%	31,562 $144,000
Q1 2021 May 14, 2021	BUY	$3.45 - $9.09 $38,074 - $100,317	11,036 New	11,036 $65,000
Q3 2020 Nov 13, 2020	SELL	$1.44 - $2.1 $305,304 - $445,235	-212,017 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.75 - $2.3 $275,828 - $362,516	157,616 Added 289.73%	212,017 $423,000
Q1 2020 May 13, 2020	BUY	$1.8 - $4.28 $39,958 - $95,011	22,199 Added 68.94%	54,401 $105,000
Q4 2019 Feb 12, 2020	BUY	$3.16 - $5.15 $18,495 - $30,142	5,853 Added 22.21%	32,202 $134,000
Q3 2019 Nov 12, 2019	SELL	$1.2 - $6.66 $1,128 - $6,260	-940 Reduced 3.44%	26,349 $80,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $13,428 - $17,846	-2,510 Reduced 8.42%	27,289 $171,000
Q1 2019 May 14, 2019	SELL	$4.36 - $7.94 $16,275 - $29,640	-3,733 Reduced 11.13%	29,799 $166,000
Q4 2018 Feb 13, 2019	SELL	$6.15 - $10.51 $165,711 - $283,191	-26,945 Reduced 44.55%	33,532 $223,000
Q3 2018 Nov 13, 2018	SELL	$10.32 - $13.06 $671,687 - $850,023	-65,086 Reduced 51.84%	60,477 $645,000
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $595,561 - $1.05 Million	76,354 Added 155.16%	125,563 $1.51 Million
Q1 2018 May 15, 2018	SELL	$7.86 - $11.39 $9,942 - $14,408	-1,265 Reduced 2.51%	49,209 $421,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $127,042 - $177,888	-14,486 Reduced 22.3%	50,474 $498,000
Q3 2017 Nov 14, 2017	SELL	$12.17 - $16.3 $30,753 - $41,190	-2,527 Reduced 3.74%	64,960 $798,000
Q2 2017 Aug 14, 2017	BUY	N/A	67,487	67,487 $1.11 Million

Others Institutions Holding LXRX

# of Institutions

122

Shares Held

159M

Call Options Held

2.11M

Put Options Held

412K

Artal Group S.A. Luxembourg, N4

118M
Shares

$188 Million
15.21% of portfolio
Black Rock Inc. New York, NY

7.69M
Shares

$12.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.4M
Shares

$10.2 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.54M
Shares

$5.67 Million
0.19% of portfolio
Geode Capital Management, LLC Boston, MA

2.39M
Shares

$3.82 Million
0.0% of portfolio

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $302M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account